Menchise Valeria, De Simone Giuseppina, Di Fiore Anna, Scozzafava Andrea, Supuran Claudiu T
Istituto di Biostrutture e Bioimmagini-CNR, via Mezzocannone 16, 80134 Naples, Italy.
Bioorg Med Chem Lett. 2006 Dec 15;16(24):6204-8. doi: 10.1016/j.bmcl.2006.09.022. Epub 2006 Sep 26.
The X-ray crystal structures of 5-amino-1,3,4-thiadiazole-2-sulfonamide (the acetazolamide precursor) and 5-(4-amino-3-chloro-5-fluorophenylsulfonamido)-1,3,4-thiadiazole-2-sulfonamide in complex with the human isozyme II of carbonic anhydrase (CA, EC 4.2.1.1) are reported. The thiadiazole-sulfonamide moiety of the two compounds binds in the canonic manner to the zinc ion and interacts with Thr199, Glu106, and Thr200. The substituted phenyl tail of the second inhibitor was positioned in the hydrophobic part of the binding pocket, at van der Waals distance from Phe131, Val 135, Val141, Leu198, Pro202, and Leu204. These structures may help in the design of better inhibitors of these widespread zinc-containing enzymes.
报道了5-氨基-1,3,4-噻二唑-2-磺酰胺(乙酰唑胺前体)和5-(4-氨基-3-氯-5-氟苯基磺酰胺基)-1,3,4-噻二唑-2-磺酰胺与碳酸酐酶(CA,EC 4.2.1.1)人同工酶II形成复合物的X射线晶体结构。这两种化合物的噻二唑-磺酰胺部分以经典方式与锌离子结合,并与Thr199、Glu106和Thr200相互作用。第二种抑制剂的取代苯基尾部位于结合口袋的疏水部分,与Phe131、Val 135、Val141、Leu198、Pro202和Leu204处于范德华距离。这些结构可能有助于设计出更好的这些广泛存在的含锌酶抑制剂。